Risk Of Developing Liver Cancer After HCV Treatment

▼
Showing posts with label a-DDW 2014 meeting. Show all posts
Showing posts with label a-DDW 2014 meeting. Show all posts
Friday, May 23, 2014

HCV genotype 4 patients achieved SVR12 with triple therapy

›
HCV genotype 4 patients achieved SVR12 with triple therapy May 23, 2014 Source - Healio CHICAGO — Hepatitis C virus genotype 4-infected...
Tuesday, May 13, 2014

Sovaldi-Hepatitis C patients achieved SVR despite negative predictors

›
HCV patients treated with sofosbuvir maintained high SVR despite negative predictors May 13, 2014 CHICAGO — Hepatitis C virus-infected pati...
Tuesday, May 6, 2014

HCV Tuesday News -Liver biopsy is becoming an endangered procedure.

›
Digestive Disease Week 2014   DDW Daily News The newspaper is distributed in the convention center four times during the conference. Eac...
1 comment:

Study Provides More Evidence that Statins Help Slow Liver Fibrosis in Hepatitis C

›
Study Provides More Evidence that Statins Help Slow Liver Fibrosis in Hepatitis C By Marcia Frellick | May 05, 2014   New research ...
Monday, May 5, 2014

Morning News Ticker - We Are on the Precipice of Treating Virtually Everyone with HCV

›
Digestive Disease Week 2014   Read up on key sessions from day two of DDW®, and find out what today and tomorrow still have in store in the...
Sunday, May 4, 2014

ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV

›
Digestive Disease Week 2014 Original Article - NEJM ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV Peter Ferenci, M....

Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3

›
Digestive Disease Week 2014 Original Article - NEJM Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3 Stefan Zeuzem, M.D., Geoffrey M....